
    
      This is a single-arm phase II clinical trial evaluating the prognostic value of FLT PET/CT
      for patients with locoregionally recurrent nasopharyngeal carcinoma. All patients will
      receive FLT PET/CT scans before and after carbon ion radiotherapy (CIRT). The sensitivity and
      specificity of reduction of FLT uptake reduction in terms of predicting the treatment outcome
      evaluated by MRI at 3 months after completion of CIRT according to RECIST 1.1. Its predictive
      value of OS, LPFS, RPFS and DMFS will be examined as well.
    
  